The weekly litigation news digest is live. Subscribe now
Non-Animal Based Protein Sources With Functional Properties - EP4017287
The patent EP4017287 was granted to Clara Foods on Dec 11, 2024. The application was filed on Aug 19, 2020 under application number EP20855636A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP4017287
- Application Number
- EP20855636A
- Filing Date
- Aug 19, 2020
- Status
- Granted And Under Opposition
- Nov 8, 2024
- Publication Date
- Dec 11, 2024
- External Links
- Slate, Register, Google Patents
Patent Summary
Recombinant ovalbumin (rOVA) as a non-animal alternative to eggs in foods and ingredients. The rOVA protein is produced through recombinant technology and provides functional properties like gelling, foaming, whipping, binding, etc. comparable to eggs. Compositions containing rOVA replace whole eggs or egg whites in foods and ingredients to provide increased protein content and functional features without using actual eggs. The rOVA can be used in baked goods, dressings, sauces, dairy substitutes, meat analogs, powders, and more.
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (6) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents